NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 338 filers reported holding NEOGENOMICS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258 | -35.5% | 21 | -8.7% | 0.00% | – |
| Q1 2023 | $400 | -99.8% | 23 | -99.9% | 0.00% | – |
| Q4 2022 | $167,872 | +7.6% | 18,168 | 0.0% | 0.00% | – |
| Q3 2022 | $156,000 | +5.4% | 18,168 | 0.0% | 0.00% | – |
| Q2 2022 | $148,000 | -94.6% | 18,168 | -92.0% | 0.00% | -100.0% |
| Q1 2022 | $2,748,000 | -66.2% | 226,296 | -5.1% | 0.01% | -61.5% |
| Q4 2021 | $8,136,000 | -29.4% | 238,479 | -0.2% | 0.01% | -31.6% |
| Q3 2021 | $11,524,000 | -13.2% | 238,908 | -18.7% | 0.02% | -13.6% |
| Q2 2021 | $13,275,000 | +25.4% | 293,927 | +33.9% | 0.02% | +15.8% |
| Q1 2021 | $10,583,000 | +28.0% | 219,449 | +42.9% | 0.02% | +18.8% |
| Q4 2020 | $8,269,000 | -13.1% | 153,587 | -40.5% | 0.02% | -20.0% |
| Q3 2020 | $9,517,000 | +10.8% | 258,011 | -7.0% | 0.02% | +5.3% |
| Q2 2020 | $8,586,000 | +3.6% | 277,431 | -7.6% | 0.02% | -9.5% |
| Q1 2020 | $8,290,000 | -44.6% | 300,326 | -41.3% | 0.02% | -25.0% |
| Q4 2019 | $14,968,000 | +38.1% | 511,815 | -9.7% | 0.03% | +33.3% |
| Q3 2019 | $10,841,000 | -18.8% | 567,005 | -6.9% | 0.02% | -16.0% |
| Q2 2019 | $13,354,000 | +3.5% | 608,901 | -3.5% | 0.02% | +4.2% |
| Q1 2019 | $12,899,000 | -4.1% | 631,110 | -40.9% | 0.02% | -20.0% |
| Q4 2018 | $13,449,000 | -47.1% | 1,067,608 | -35.5% | 0.03% | -37.5% |
| Q3 2018 | $25,424,000 | -21.3% | 1,656,224 | -32.7% | 0.05% | -28.4% |
| Q2 2018 | $32,296,000 | +47.9% | 2,462,218 | -8.0% | 0.07% | +81.1% |
| Q1 2018 | $21,836,000 | -6.9% | 2,676,008 | +1.5% | 0.04% | -5.1% |
| Q4 2017 | $23,456,000 | -15.6% | 2,635,487 | +5.6% | 0.04% | -17.0% |
| Q3 2017 | $27,786,000 | +55.3% | 2,496,623 | +25.0% | 0.05% | +46.9% |
| Q2 2017 | $17,891,000 | +88.6% | 1,996,710 | +66.1% | 0.03% | +88.2% |
| Q1 2017 | $9,487,000 | -28.5% | 1,202,429 | -21.1% | 0.02% | -34.6% |
| Q4 2016 | $13,263,000 | – | 1,524,506 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |